Abstract

Three new bismacrocyclic Ln(3+) chelates consisting of triamide derivatives of cyclen with glycine, methyl and tert-butyl substituents (, respectively) linked to an acyclic EGTA-derived calcium chelator were synthesised as potential MRI contrast agents (EGTA - ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid). Eu(3+) and Yb(3+) complexes of were investigated as chemical exchange saturation transfer (CEST) agents. Moderate to minor CEST effects were observed for , and complexes in the absence of Ca(2+), with negligible changes upon addition of this metal ion. Luminescence steady-state emission and lifetime experiments did not reveal any changes in the coordination environment of the complexes, while the number of inner-sphere water molecules remained constant in the absence and presence of Ca(2+). The protonation constants of and and stability constants of their complexes with Ca(2+), Mg(2+) and Zn(2+) were determined by means of potentiometric titrations. The results show that the charge of the complex dramatically affects the protonation constants of the EGTA-binding unit. The stability constants of the complexes formed with Ca(2+), Mg(2+) and Zn(2+) are several orders of magnitude lower than those of EGTA. These findings indicate that the nature of Ln(3+) chelates and their charge are the main reasons for the observed results and weaker response of these EGTA-derived triamide derivatives compared to their tricarboxylate analogues.

Highlights

  • The continuous development of contrast agents (CAs) for magnetic resonance imaging (MRI) has provided a wide range of structurally different compounds with a range of diagnostic and therapeutic applications.[1,2] The first generation and the most widely used MRI contrast agents are based on paramagnetic Gd3+ complexes or superparamagnetic iron–oxide nanoparticles (T1- and T2-shortening agents, respectively)

  • In this work we synthesised three different bismacrocyclic DO3A-amide derivatives appended with the EGTA-derived chelator

  • The luminescence steady-state emission and lifetime measurements confirmed the insensitivity of Eu2L1–3 towards Ca2+ as the inner-sphere hydration of the complexes remained intact in the presence and absence of Ca2+

Read more

Summary

Introduction

The continuous development of contrast agents (CAs) for magnetic resonance imaging (MRI) has provided a wide range of structurally different compounds with a range of diagnostic and therapeutic applications.[1,2] The first generation and the most widely used MRI contrast agents are based on paramagnetic Gd3+ complexes or superparamagnetic iron–oxide nanoparticles (T1- and T2-shortening agents, respectively). Various physicochemical aspects were investigated, including their CEST effect, hydration number assessment by means of time-resolved luminescence decay measurements, NMR studies and estimations of stability constants with endogenous metal ions by means of potentiometric titrations.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.